Eloqua Announces Fourth Quarter And Full Year 2012 Financial Results
About Eloqua
| ELOQUA, INC. | ||||||||
| UNAUDITED CONSOLIDATED BALANCE SHEETS | ||||||||
| (IN THOUSANDS, EXCEPT SHARE DATA) | ||||||||
| December 31, 2012 | December 31, 2011 | |||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 92,914 | $ | 7,240 | ||||
| Accounts receivable, net of reserve of $615 and $725, respectively | 30,802 | 18,228 | ||||||
| Deferred commissions and other deferred costs | 1,846 | 2,680 | ||||||
| Deferred tax asset | 572 | 781 | ||||||
| Prepaid expense and other assets | 3,100 | 4,153 | ||||||
| Total current assets | 129,234 | 33,082 | ||||||
| Property and equipment, net of accumulated depreciation and amortization of $9,505 and 7,242, respectively | 6,193 | 3,721 | ||||||
| Deferred commissions and other deferred costs | 526 | 902 | ||||||
| Deferred tax asset | 3,965 | 3,800 | ||||||
| Total assets | $ | 139,918 | $ | 41,505 | ||||
| LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 3,846 | $ | 3,263 | ||||
| Accrued employee compensation and related costs | 13,356 | 3,479 | ||||||
| Accrued and other current liabilities | 7,531 | 7,858 | ||||||
| Deferred revenue, current portion | 38,148 | 28,863 | ||||||
| Current portion of long-term debt | - | 834 | ||||||
| Total current liabilities | 62,881 | 44,297 | ||||||
| Long-term debt, net of current portion | - | 1,458 | ||||||
| Non current deferred revenue and other liabilities | 2,545 | 1,943 | ||||||
| Total liabilities | 65,426 | 47,698 | ||||||
| Redeemable convertible preferred stock: | ||||||||
| Series A preferred stock, $0.0001 par value, 12,124,650 shares authorized, | - | 39,406 | ||||||
| issued and outstanding at December 31, 2011 and no shares outstanding at December 31, 2012; | ||||||||
| liquidation preference of $39,406 at December 31, 2011 | ||||||||
| Series B preferred stock, $0.0001 par value, 17,678,926 shares authorized, | - | 57,456 | ||||||
| issued and outstanding at December 31, 2011 and no shares outstanding at December 31, 2012; | ||||||||
| liquidation preference of $57,456 at December 31, 2011 | ||||||||
| Series C preferred stock, $0.0001 par value, 21,483,563 shares authorized, | - | 64,242 | ||||||
| and 19,766,821 shares issued and outstanding at December 31, 2011 and no shares outstanding at December 31, 2012; | ||||||||
| liquidation preference of $64,242 at December 31, 2011 | ||||||||
| Total redeemable convertible preferred stock | - | 161,104 | ||||||
| Stockholders' equity (deficit) | ||||||||
| Eloqua, Inc. stockholders' equity (deficit): | ||||||||
| Common stock, $0.0001 par value; 100,000,000 and 90,000,000 shares authorized, 35,525,498 and 1,063,368 | ||||||||
| shares issued and outstanding at December 31, 2012 and December 31, 2011 | 3 | - | ||||||
| Additional paid-in capital | 319,070 | - | ||||||
| Accumulated deficit | (244,581 | ) | (169,259 | ) | ||||
| Total Eloqua, Inc. stockholders' equity (deficit) | 74,492 | (169,259 | ) | |||||
| Noncontrolling interest | - | 1,962 | ||||||
| Total stockholders' equity (deficit) | 74,492 | (167,297 | ) | |||||
| Total liabilities, redeemable preferred stock and stockholders' equity | $ | 139,918 | $ | 41,505 | ||||
| ELOQUA, INC. | ||||||||||||||||
| UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||
| (IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA) | ||||||||||||||||
| Three months ended December 31, | Twelve months ended December 31, | |||||||||||||||
| 2012 | 2011 | 2012 | 2011 | |||||||||||||
| Revenue: | ||||||||||||||||
| Subscription and support | $ | 22,879 | $ | 17,925 | $ | 83,906 | $ | 63,222 | ||||||||
| Professional services | 4,084 | 3,382 | 11,856 | 8,126 | ||||||||||||
| Total revenue | 26,963 | 21,307 | 95,762 | 71,348 | ||||||||||||
| Cost of revenue: | ||||||||||||||||
| Subscription and support | 4,806 | 3,191 | 15,758 | 12,330 | ||||||||||||
| Professional services | 3,714 | 3,415 | 11,537 | 10,718 | ||||||||||||
| Total cost of revenue | 8,520 | 6,606 | 27,295 | 23,048 | ||||||||||||
| Gross profit | 18,443 | 14,701 | 68,467 | 48,300 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Research and development | 3,821 | 3,207 | 13,664 | 11,679 | ||||||||||||
| Marketing and sales | 11,288 | 8,071 | 40,708 | 29,481 | ||||||||||||
| General and administrative | 7,109 | 4,485 | 21,419 | 12,208 | ||||||||||||
| Litigation settlement | - | - | 3,500 | - | ||||||||||||
| Total operating expenses | 22,218 | 15,763 | 79,291 | 53,368 | ||||||||||||
| Loss from operations | (3,775 | ) | (1,062 | ) | (10,824 | ) | (5,068 | ) | ||||||||
| Other income (expense), net | 34 | (237 | ) | (288 | ) | (707 | ) | |||||||||
| Loss before benefit (provision) for income taxes | (3,741 | ) | (1,299 | ) | (11,112 | ) | (5,775 | ) | ||||||||
| Benefit (provision) for income taxes | 46 | (102 | ) | (152 | ) | (378 | ) | |||||||||
| Net loss | (3,695 | ) | (1,401 | ) | (11,264 | ) | (6,153 | ) | ||||||||
| Accretion of dividends on redeemable preferred stock | - | (17,351 | ) | (66,920 | ) | (89,659 | ) | |||||||||
| Net loss attributable to common stockholders | $ | (3,695 | ) | $ | (18,752 | ) | $ | (78,184 | ) | $ | (95,812 | ) | ||||
| Net loss per share attributable to common stockholders, basic and diluted | $ | (0.11 | ) | $ | (19.09 | ) | $ | (5.40 | ) | $ | (116.74 | ) | ||||
| Weighted average common shares outstanding, basic and diluted | 34,375,057 | 982,471 | 14,490,578 | 820,734 | ||||||||||||
| ELOQUA, INC. | ||||||||||||||||
| UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||||||||||
| (IN THOUSANDS) | ||||||||||||||||
| Three months ended December 31, | Twelve months ended December 31, | |||||||||||||||
| 2012 | 2011 | 2012 | 2011 | |||||||||||||
| Cash flows from operating activities: | ||||||||||||||||
| Net loss | $ | (3,695 | ) | $ | (1,401 | ) | $ | (11,264 | ) | $ | (6,153 | ) | ||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | ||||||||||||||||
| Depreciation and amortization | 739 | 506 | 2,263 | 1,872 | ||||||||||||
| Stock-based compensation expense | 1,196 | 682 | 3,547 | 1,812 | ||||||||||||
| Foreign currency transaction gain (loss) | 3 | 44 | (41 | ) | 65 | |||||||||||
| Deferred income taxes | (87 | ) | 52 | 40 | 264 | |||||||||||
| Loss on disposal of fixed assets | - | 173 | - | 173 | ||||||||||||
| Change in fair value of Series C warrants | - | 51 | 189 | 264 | ||||||||||||
| Change in operating assets and liabilities: | ||||||||||||||||
| Accounts receivable, net | (10,876 | ) | (6,997 | ) | (12,574 | ) | (2,362 | ) | ||||||||
| Prepaid expenses and other assets | 494 | (1,185 | ) | (464 | ) | (2,102 | ) | |||||||||
| Deferred commissions and other deferred costs | 176 | 1,005 | 1,210 | (59 | ) | |||||||||||
| Accounts payable and accrued and other current liabilities | 3,976 | 4,746 | 808 | 5,200 | ||||||||||||
| Deferred revenue | 5,672 | 570 | 9,285 | 3,492 | ||||||||||||
| Noncurrent deferred revenue and other liabilities | (254 | ) | 788 | 606 | 271 | |||||||||||
| Net cash (used in) provided by operating activities | (2,656 | ) | (966 | ) | (6,395 | ) | 2,737 | |||||||||
| Cash flows from investing activities: | ||||||||||||||||
| Purchases of property and equipment | (1,869 | ) | (669 | ) | (4,735 | ) | (2,898 | ) | ||||||||
| Net cash used in investing activities | (1,869 | ) | (669 | ) | (4,735 | ) | (2,898 | ) | ||||||||
| Cash flows from financing activities: | ||||||||||||||||
| Repayment of long-term debt | - | (208 | ) | (2,292 | ) | (208 | ) | |||||||||
| Net IPO Proceeds | - | - | 85,760 | - | ||||||||||||
| Tax withholdings on stock options exercised | 9,708 | 9,708 | ||||||||||||||
| Principal payments under capital lease obligations | - | (152 | ) | - | (321 | ) | ||||||||||
| Common stock issued | 2,261 | 84 | 3,587 | 446 | ||||||||||||
| Net cash provided by (used in) financing activities | 11,969 | (276 | ) | 96,763 | (83 | ) | ||||||||||
| Effect of exchange rate changes of cash and cash equivalents | (3 | ) | (44 | ) | 41 | (65 | ) | |||||||||
| Net increase (decrease) in cash and cash equivalents | 7,441 | (1,955 | ) | 85,674 | (309 | ) | ||||||||||
| Cash and cash equivalents at beginning of the period | 85,473 | 9,195 | 7,240 | 7,549 | ||||||||||||
| Cash and cash equivalents at end of the period | $ | 92,914 | $ | 7,240 | $ | 92,914 | $ | 7,240 | ||||||||
| ELOQUA, INC. | ||||||||||||
| UNAUDITED SUMMARY OF STOCK-BASED COMPENSATION INCLUDED IN THE CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||
| (IN THOUSANDS) | ||||||||||||
| Three months ended December 31, | Twelve months ended December 31, | |||||||||||
| 2012 | 2011 | 2012 | 2011 | |||||||||
| Cost of revenue | $ | 203 | $ | 89 | $ | 573 | $ | 284 | ||||
| Sales and marketing | 454 | 177 | 1,160 | 514 | ||||||||
| Research and development | 134 | 91 | 439 | 313 | ||||||||
| General and administrative | 405 | 325 | 1,375 | 701 | ||||||||
| Total Stock-Based Compensation Expense | $ | 1,196 | $ | 682 | $ | 3,547 | $ | 1,812 | ||||
| ELOQUA, INC. | ||||||||||||||||
| UNAUDITED NON-GAAP OPERATING LOSS, NON-GAAP NET LOSS, NON-GAAP NET LOSS PER SHARE AND FREE CASH FLOW RECONCILIATIONS TO GAAP | ||||||||||||||||
| (IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA) | ||||||||||||||||
| Three months ended December 31, | Twelve months ended December 31, | |||||||||||||||
| 2012 | 2011 | 2012 | 2011 | |||||||||||||
| Reconciliation of Loss From Operations to Non-GAAP Operating Loss | ||||||||||||||||
| Loss From Operations | $ | (3,775 | ) | $ | (1,062 | ) | $ | (10,824 | ) | $ | (5,068 | ) | ||||
| Adjustments to loss from operations: | ||||||||||||||||
| Stock-based compensation expense | 1,196 | 682 | 3,547 | 1,812 | ||||||||||||
| Non-GAAP Operating Loss | $ | (2,579 | ) | $ | (380 | ) | $ | (7,277 | ) | $ | (3,256 | ) | ||||
| Reconciliation of Net Loss to Non-GAAP Net Loss Per Share | ||||||||||||||||
| Net Loss | $ | (3,695 | ) | $ | (1,401 | ) | $ | (11,264 | ) | $ | (6,153 | ) | ||||
| Accretion of dividends on redeemable preferred stock | - | (17,351 | ) | (66,920 | ) | (89,659 | ) | |||||||||
| Net loss attributable to common stockholders | (3,695 | ) | (18,752 | ) | (78,184 | ) | (95,812 | ) | ||||||||
| Adjustments to net loss attributable to common stockholders: | ||||||||||||||||
| Accretion of dividends on redeemable preferred stock | - | 17,351 | 66,920 | 89,659 | ||||||||||||
| Stock-based compensation expense | 1,196 | 682 | 3,547 | 1,812 | ||||||||||||
| Change in fair value of Series C warrants | - | 51 | 189 | 264 | ||||||||||||
| Income tax (benefit) expense | (46 | ) | 102 | 152 | 378 | |||||||||||
| Total adjustments to net loss from common stockholders | 1,150 | 18,186 | 70,808 | 92,113 | ||||||||||||
| Non-GAAP Net Loss | $ | (2,545 | ) | $ | (566 | ) | $ | (7,376 | ) | $ | (3,699 | ) | ||||
| Pro forma weighted average common shares outstanding, basic and diluted** | 34,375,057 | 32,588,175 | 33,478,768 | 32,426,411 | ||||||||||||
| Non-GAAP Net Loss Per Share | $ | (0.07 | ) | $ | (0.02 | ) | $ | (0.22 | ) | $ | (0.11 | ) | ||||
| ** The pro forma weighted average common shares outstanding reflects 1) the conversion of preferred stock into common stock 2) the conversion of exchangeable shares into common stock and 3) the 8.2 million shares of common stock issued upon the initial public offering completed on August 7, 2012 as if these shares were outstanding for all periods included in the calculation. | ||||||||||||||||
| Reconciliation of Net Cash (Used In) Provided By Operating Activities to Free Cash Flow | ||||||||||||||||
| Net Cash (Used In) Provided By Operating Activities | $ | (2,656 | ) | $ | (966 | ) | $ | (6,395 | ) | $ | 2,737 | |||||
| Less: | ||||||||||||||||
| Purchases of property and equipment | (1,869 | ) | (669 | ) | (4,735 | ) | (2,898 | ) | ||||||||
| Free Cash Flow | $ | (4,525 | ) | $ | (1,635 | ) | $ | (11,130 | ) | $ | (161 | ) | ||||
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
